France, Germany, Netherlands160 participantsStarted 2017-12-10
Plain-language summary
The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available G7 BiSpherical Acetabular Shell.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient capable of understanding the surgeon's explanations and following his instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study.
* Patient aged of 18 years or more whose skeleton reached bone maturity.
* Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
* Rheumatoid arthritis.
* Correction of functional deformity.
* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
* Revision procedures where other treatment or devices have failed.
Inclusion criteria specific for patients receiving the G7 BiSpherical Shell with the G7 Freedom Constrained Liner:
* The Biomet G7 Freedom Constrained Liner is indicated for use as a component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease, or intraoperative instability, and for whom all other options to con-strained acetabular components have been considered.
Exclusion Criteria:
Absolute exclusion criteria include:
* Infection, sepsis, osteomyelitis.
Relative exclusion criteria include:
* Uncooperative patient or patient with neurologic disorders who is incapable of following directions.
* Osteoporosis.
* Metabolic disorders which may impair bone formation.
* Osteomalaci…
What they're measuring
1
Implant survivorship is assessed counting the number of implant revisions